Literature DB >> 31786195

Interstitial HIF1A induces an estimated glomerular filtration rate decline through potentiating renal fibrosis in diabetic nephropathy.

Xiyue Li1, Sisi Yang1, Minhua Yan1, Nan Guan1, Jing Li1, Qionghong Xie1, Chuanming Hao2.   

Abstract

AIMS: This study aimed to identify interstitial molecules that were responsible for the deterioration of the esiantimated glomerular filtration rate (eGFR) in diabetic nephropathy (DN).
MATERIALS AND METHODS: Weighted gene co-expression network analysis (WGCNA) was used to link the tubulointerstitial gene expression profile of DN to eGFR values. The relationship of eGFR with each sub-domain regulator in the network was analyzed with the linear regression model. Gene sets enrichment analysis (GSEA) was applied to detect the molecular changes mostly relating to the essential regulators. KEY
FINDINGS: Four co-expression modules were found strongly correlating with eGFR values. Genes from these modules were over-represented in fibrosis-related biological processes (extracellular matrix (ECM) organization and cell adhesion) and pathways (integrin signaling and ECM-receptor interaction). Of sub-domains in the gene interaction network, the expression of hypoxia-inducible factor 1A (HIF1A) was most negatively correlated with eGFR (R2 = 0.417, P = 0.026). The positive correlations between HIF1A and its target genes were found, indicating an enhanced transcriptional activity of HIF1A. We also found that HIF1A positively correlated with CCAAT enhancer binding protein delta (CEBPD) (r = 0.731, P = 0.011), an activator of HIF1A transcription. Moreover, GSEA showed that samples with high HIF1A expression were enriched with fibrosis associated signaling, like ECM-receptor interaction and cell adhesion. Intriguingly, vascular epithelial growth factor A (VEGFA) expression decreased while HIF1A increased (R2 = 0.733, P = 0.001), suggesting VEGFA loss may exacerbate hypoxia and stimulate HIF1A induction. SIGNIFICANCE: The present study suggested that interstitial HIF1A may be involved in renal interstitial fibrosis in DN.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Diabetic nephropathy; Glomerular filtration rate; HIF1A; Renal fibrosis; VEGFA

Mesh:

Substances:

Year:  2019        PMID: 31786195     DOI: 10.1016/j.lfs.2019.117109

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.

Authors:  Song-Tao Feng; Yang Yang; Jin-Fei Yang; Yue-Ming Gao; Jing-Yuan Cao; Zuo-Lin Li; Tao-Tao Tang; Lin-Li Lv; Bin Wang; Yi Wen; Lin Sun; Guo-Lan Xing; Bi-Cheng Liu
Journal:  Clin Kidney J       Date:  2021-09-28

2.  Comparative transcriptomic analysis of rat versus mouse cerebral cortex after traumatic brain injury.

Authors:  Meng-Shi Yang; Xiao-Jian Xu; Bin Zhang; Fei Niu; Bai-Yun Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

3.  Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease.

Authors:  Shanshan Liu; Cuili Wang; Huiying Yang; Tingting Zhu; Hong Jiang; Jianghua Chen
Journal:  Ann Transl Med       Date:  2020-11

4.  Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1α in the Serum of Patients with Chronic Kidney Disease.

Authors:  Tianbiao Zhou; Wenshan Lin; Shujun Lin; Zhiqing Zhong; Yuanyuan Luo; Zhijun Lin; Weiji Xie; Weitao Shen; Kai Hong
Journal:  Biomed Res Int       Date:  2020-08-20       Impact factor: 3.411

5.  Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic Nephropathy.

Authors:  Jingxue Han; Xinwei Wang; Jingyi Hou; Yu Liu; Peng Liu; Tingting Zhao
Journal:  Biomed Res Int       Date:  2021-02-01       Impact factor: 3.411

6.  Urinary Extracellular Vesicles as a Source of NGAL for Diabetic Kidney Disease Evaluation in Children and Adolescents With Type 1 Diabetes Mellitus.

Authors:  Francisca Ugarte; Daniela Santapau; Vivian Gallardo; Carolina Garfias; Anahí Yizmeyián; Soledad Villanueva; Carolina Sepúlveda; Jocelyn Rocco; Consuelo Pasten; Cinthya Urquidi; Gabriel Cavada; Pamela San Martin; Francisco Cano; Carlos E Irarrázabal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.